2 assets in Inherited Neurodegenerative Disorder

Therapeutic assets addressing Inherited Neurodegenerative Disorder, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Nexiguran Ziclumeran Inherited Neurodegenerative Disorder	Intellia Therapeutics	P3	B (60)
Lenalidomide Inherited Neurodegenerative Disorder	St. Joseph's Hospital and Medical Center, Phoenix	P2	CCC (53)